BlackRock’s Kezar Life Sciences KZR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$447K Buy
97,671
+15,057
+18% +$69K ﹤0.01% 4401
2025
Q1
$403K Sell
82,614
-241
-0.3% -$1.18K ﹤0.01% 4405
2024
Q4
$557K Sell
82,855
-3
-0% -$20 ﹤0.01% 4332
2024
Q3
$641K Sell
82,858
-179
-0.2% -$1.38K ﹤0.01% 4222
2024
Q2
$498K Sell
83,037
-378,662
-82% -$2.27M ﹤0.01% 4292
2024
Q1
$4.16M Sell
461,699
-20,028
-4% -$181K ﹤0.01% 3692
2023
Q4
$4.56M Sell
481,727
-13,502
-3% -$128K ﹤0.01% 3654
2023
Q3
$5.89M Sell
495,229
-13,686
-3% -$163K ﹤0.01% 3543
2023
Q2
$12.5M Buy
508,915
+63,116
+14% +$1.55M ﹤0.01% 3237
2023
Q1
$14M Buy
445,799
+22,708
+5% +$711K ﹤0.01% 3084
2022
Q4
$29.8M Buy
423,091
+12,598
+3% +$887K ﹤0.01% 2765
2022
Q3
$35.3M Buy
410,493
+52,514
+15% +$4.52M ﹤0.01% 2674
2022
Q2
$29.6M Buy
357,979
+68,272
+24% +$5.65M ﹤0.01% 2815
2022
Q1
$48.2M Buy
289,707
+21,005
+8% +$3.49M ﹤0.01% 2575
2021
Q4
$44.9M Buy
268,702
+5,520
+2% +$923K ﹤0.01% 2687
2021
Q3
$22.7M Buy
263,182
+3,202
+1% +$277K ﹤0.01% 3144
2021
Q2
$14.1M Sell
259,980
-981
-0.4% -$53.3K ﹤0.01% 3441
2021
Q1
$15.6M Buy
260,961
+9,052
+4% +$539K ﹤0.01% 3265
2020
Q4
$13.2M Buy
251,909
+52,479
+26% +$2.74M ﹤0.01% 3164
2020
Q3
$9.65M Sell
199,430
-6,660
-3% -$322K ﹤0.01% 3160
2020
Q2
$10.7M Buy
206,090
+26,301
+15% +$1.36M ﹤0.01% 3084
2020
Q1
$7.84M Buy
179,789
+88,909
+98% +$3.88M ﹤0.01% 3072
2019
Q4
$3.64M Buy
90,880
+989
+1% +$39.7K ﹤0.01% 3536
2019
Q3
$2.95M Buy
89,891
+5,452
+6% +$179K ﹤0.01% 3588
2019
Q2
$6.51M Buy
84,439
+20,881
+33% +$1.61M ﹤0.01% 3403
2019
Q1
$11.3M Buy
63,558
+38,965
+158% +$6.91M ﹤0.01% 3036
2018
Q4
$5.8M Buy
24,593
+448
+2% +$106K ﹤0.01% 3328
2018
Q3
$5.17M Buy
24,145
+23,145
+2,315% +$4.95M ﹤0.01% 3457
2018
Q2
$173K Buy
+1,000
New +$173K ﹤0.01% 4284